This is a preview of subscription content, log in via an institution to check access.
References
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Polaprezinc. Internet Document : [1 page], 22 Nov 2016. Available from: URL: http://www.pmda.go.jp/files/000215039.pdf.
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Products containing Formalin. Internet Document : [4 pages], 22 Nov 2016. Available from: URL: http://www.pmda.go.jp/files/000215040.pdf.
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Allopurinol. Internet Document : [2 pages], 22 Nov 2016. Available from: URL: http://www.pmda.go.jp/files/000215041.pdf.
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Alogliptin benzoate-containing drugs, Linagliptin, Teneligliptin hydrobromide hydrate. Internet Document : [2 pages], 22 Nov 2016. Available from: URL: http://www.pmda.go.jp/files/000215042.pdf.
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Zoledronic acid hydrate. Internet Document : [2 pages], 22 Nov 2016. Available from: URL: http://www.pmda.go.jp/files/000215043.pdf.
Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Famciclovir. Internet Document : [2 pages], 22 Nov 2016. Available from: URL: http://www.pmda.go.jp/files/000215044.pdf.
Rights and permissions
About this article
Cite this article
Investigation results from Japan's PMDA. Reactions Weekly 1630, 1 (2016). https://doi.org/10.1007/s40278-016-23525-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-23525-0